Health and Fitness Health and Fitness
Fri, February 10, 2012
Thu, February 9, 2012
Wed, February 8, 2012
[ Wed, Feb 08th 2012 ] - Market Wire
Imaging3 Updates Website
Tue, February 7, 2012
Mon, February 6, 2012
Sun, February 5, 2012
[ Sun, Feb 05th 2012 ] - Market Wire
30 a.m. ET
Sat, February 4, 2012
Fri, February 3, 2012
Thu, February 2, 2012
Wed, February 1, 2012
Tue, January 31, 2012
Mon, January 30, 2012

Neurocrine Biosciences to Present at the 14th Annual BIO CEO amp;; Investor Conference


//health-fitness.news-articles.net/content/2012/ .. nnual-bio-ceo-amp-59-59-investor-conference.html
Published in Health and Fitness on Monday, February 6th 2012 at 14:06 GMT by Market Wire   Print publication without navigation


Neurocrine Biosciences to Present at the 14th Annual BIO CEO & Investor... -- SAN DIEGO, Feb. 6, 2012 /PRNewswire/ --

Neurocrine Biosciences to Present at the 14th Annual BIO CEO & Investor Conference

[ ]

LIVE AUDIO WEBCAST MONDAY, FEBRUARY 13, 2012

SAN DIEGO, Feb. 6, 2012 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: [ NBIX ]) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the 14th Annual BIO CEO & Investor Conference in New York.   

The live presentation takes place on Monday, February 13 at 11:30 a.m. Eastern Time / 8:30 a.m. Pacific Time.  The presentation will be webcast and may be accessed on the Company's website at [ http://www.neurocrine.com ].

If you are unable to attend the webcast and would like further information on this announcement please contact Investor Relations at Neurocrine Biosciences at (858) 617-7600.  Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.  A replay of the presentation will be available approximately one hour after the conclusion of the live event and will be archived on the website for two weeks.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, stress-related disorders, tardive dyskinesia, uterine fibroids, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at [ http://www.neurocrine.com ].

SOURCE Neurocrine Biosciences, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.neurocrine.com ]


Publication Contributing Sources